Remove Labelling Remove Medication Therapy Management (MTM) Remove Specialty Pharmacies
article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

3 ,4, 5 As such, the NHC supports CMS proposal to ensure that Part D sponsors cover AOMs for obesity with clinical criteria that is not more restrictive than the FDA labeling for each AOM. 38 American Medical Association. 14 National Health Council. 2 (2024): 206 214, [link] www.jmcp.org/doi/epdf/10.18553/jmcp.2024.30.2.206.